In 2013, HIU received a request from the Rockefeller Foundation, to support the development of UHC in Vietnam. Since then, the Vietnam engagement has moved under the umbrella of iDSI projects. The Health Strategy and Policy Institute (HSPI), was appointed by the Ministry of Health to be the country

You are invited to join a webinar hosted by the Health Intervention Technology Assessment Program (HITAP, Thailand) that will feature a guest lecture by Assistant Professor Wenjia Chen from the Saw Swee Hock School of Public Health, National University of Singapore (SSHSPH NUS). She will be discussi

Asst. Prof Hannah Clapham during the policy conference session “Charting a path to sustainable immunization programs and preparedness/response strategies” The development, delivery, access, and perceptions around vaccination were all significantly impacted by pandemics. The pand

HITAP emphasise the lead role of Thailand in public health system as the host of the Health Technology Assessment (HTA) conference at the regional level gathering around 300 academics from 20 countries to present their research work, build a network for health policy recommendations development, and

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,

Provider-initiated HIV/AIDS counselling and testing at healthcare facilities in Thailand: a cluster-randomisation trial. Yot Teerawattananon1, Yuwadee Leelukkanaveera1,2,3, Montarat Thavorncharoensap1,4, Piya Hanvoravongchai5, Lily Ingsrisawang1,6, Sripen Tantivess1, Usa Chaikledkaew1,4, Adun Mohar

Balancing the right to know and the privacy of the patent system: a case study of oncology medicines in Thailand. Inthira Yamabhai; Richard D. Smith Abstract: This study aims to illustrate the processes to determine medicine patent status in developing countries by using oncology medicine in T

Aronrag Meeyai1,2, Naiyana Praditsitthikorn1,3, Surachai Kotirum1, Wantanee Kulpeng1,Weerasak Putthasri4, Ben S. Cooper5,6*, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Nonthaburi, Thailand, 2 Department of Epidemiology, Faculty of Public Health, Mahidol University

About the study Objective: This study aimed to quantify heterogeneity in the value for money of precision medicine (PM) by application types across contexts and conditions and to quantify sources of heterogeneity to areas of particular promises or concerns as the field of PM moves forward. Methods

Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff